
Berry Genomics Co.,Ltd — Investor Relations & Filings
Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 半年报董事会决议公告 | 2024-08-22 | Chinese | |
| 2024年半年度报告 | 2024-08-22 | Chinese | |
| 关于为控股子公司提供担保额度的进展公告 | 2024-08-22 | Chinese | |
| 关于向参股公司提供借款的公告 | 2024-08-22 | Chinese | |
| 第十届董事会第九次会议决议公告 | 2024-07-24 | Chinese | |
| 关于全资子公司出售资产进展暨完成产权过户的公告 | 2024-07-24 | Chinese |
Browse filings by year
27 years- 2026 23 filings
- 2025 83 filings
- 2024 89 filings
- 2023 127 filings
- 2022 106 filings
- 2021 125 filings
- 2020 162 filings
- 2019 112 filings
- 2018 131 filings
- 2017 154 filings
- 2016 161 filings
- 2015 76 filings
- 2014 146 filings
- 2013 52 filings
- 2012 68 filings
- 2011 33 filings
- 2010 44 filings
- 2009 45 filings
- 2008 34 filings
- 2007 52 filings
- 2006 59 filings
- 2005 39 filings
- 2004 18 filings
- 2003 34 filings
- 2002 29 filings
- 2001 5 filings
- 1997 2 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 43276556 | 半年报董事会决议公告 | 2024-08-22 | Chinese | ||
| 43276521 | 2024年半年度报告 | 2024-08-22 | Chinese | ||
| 43276506 | 关于为控股子公司提供担保额度的进展公告 | 2024-08-22 | Chinese | ||
| 43276469 | 关于向参股公司提供借款的公告 | 2024-08-22 | Chinese | ||
| 43276425 | 第十届董事会第九次会议决议公告 | 2024-07-24 | Chinese | ||
| 43276375 | 关于全资子公司出售资产进展暨完成产权过户的公告 | 2024-07-24 | Chinese | ||
| 43276340 | 关于聘任公司董事会秘书的公告 | 2024-07-24 | Chinese | ||
| 43276306 | 关于控股股东之一致行动人被司法拍卖的股份完成过户暨股东持股比例变动超过1%的公告 | 2024-07-22 | Chinese | ||
| 43276282 | 关于控股股东之一致行动人所持公司部分股份被司法拍卖的进展公告 | 2024-07-16 | Chinese | ||
| 43276252 | 2024年半年度业绩预告 | 2024-07-12 | Chinese | ||
| 43276216 | 关于控股股东被动减持股份的预披露公告 | 2024-07-09 | Chinese | ||
| 43276164 | 关于控股股东之一致行动人所持公司部分股份将被司法拍卖的提示性公告 | 2024-06-17 | Chinese | ||
| 43276131 | 简式权益变动报告书 | 2024-06-17 | Chinese | ||
| 43276101 | 北京市金杜律师事务所关于贝瑞基因2023年年度股东大会之法律意见书 | 2024-05-17 | Chinese | ||
| 43276055 | 2023年年度股东大会决议公告 | 2024-05-17 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Berry Genomics Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53769/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53769 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53769 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53769 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53769}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Berry Genomics Co.,Ltd (id: 53769)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.